https://www.selleckchem.com/pr....oducts/bsj-03-123.ht
© 2020 John Wiley Sons Ltd. Mass Spec Rev.Pancreatic cancer is a disease with a high mortality rate. Although survival rates for different types of cancers have improved in recent years, the five-year survival rate of pancreatic cancer stands at 8%. Moreover, the current first-line therapy, gemcitabine, results in low remission rates and is associated with drug resistance problems. Alternative treatments for pancreatic cancer such as surgery, chemotherapy and radiation therapy provide marginal remission and survival rates. This
Like
Comment
Share
